Bacterium that may protect against long COVID identified
Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
According to WHO, approximately 6% of the worldwide population who contract COVID-19—some 400 million people—go on to develop a long-lasting form of the disease. These figures demonstrate that the persistent form of the disease remains a problem and is a major public health challenge. In 2021, in the midst of the COVID-19 pandemic, University of Louvain (UCLouvain, Belgium) and its hospital, the Cliniques universitaires Saint-Luc, launched a large-scale study to determine whether it is possible to predict, during the acute phase of infection, the development of long-term symptoms.